Publications
- Indications for allogeneic and autologous haematopoietic cell transplantations in the Czech Republic in 2016: Recommendations of the Transplant Section of the Czech Society of Haematology and the Czech Society of Oncology of the J. E. Purkyně Medical Association2016 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Stem cell transplantation on non-malignant diseases in adults2012 | First Faculty of Medicine
- High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience2010 | First Faculty of Medicine, Third Faculty of Medicine
- KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation2009 | First Faculty of Medicine
- HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis2009 | First Faculty of Medicine
- Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT2021 | First Faculty of Medicine
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial2019 | First Faculty of Medicine
- Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma2018 | Faculty of Medicine in Hradec Králové
- High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO2018 | Publication without faculty affiliation
- Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party2018 | Publication without faculty affiliation
Loading network view...